Australian data do not support current Pharmaceutical Benefits Scheme criteria for use of tumour necrosis factor-alpha inhibitors in ankylosing spondylitis.

Authors :: Schachna L
Brown MA
Source :: Internal medicine journal [Intern Med J] 2006 Nov; Vol. 36 (11), pp. 755-6.
Publication Year :: 2006

Subjects :: Australia
Humans
Pharmaceutical Services economics
Tumor Necrosis Factor Decoy Receptors
Antirheumatic Agents therapeutic use
Neoplasm Proteins therapeutic use
Receptors, Tumor Necrosis Factor, Type II therapeutic use
Spondylitis, Ankylosing drug therapy

Full Text Access

Tools